Rising to the Challenge:
Dermatologic Diagnosis and Decision-Making

Target Audience

This activity has been designed to meet the educational needs of pediatricians, nurse practitioners, and physician assistants involved in the front-line management of patients with atopic dermatitis (AD). No prerequisites required.

Program Overview

Atopic dermatitis (AD) is a chronic, pruritic, inflammatory skin disease, associated with a heterogeneous presentation and clinical course. AD is commonly seen in pediatric primary care; about 20% to 30% of children in primary care present with a skin-related complaint. AD can be difficult to diagnose, because several other skin disorders mimic its presentation. Moreover, many cases of AD do not resolve and recur, causing significant burden for both the patient and their parents and family members. Management of patients with AD requires a thorough and multifaceted approach that begins with basic skin care and appropriate use of topical and, when necessary, systemic treatments.

This unique game features 6 cases of common skin conditions seen in pediatric primary care. As the player, your goal in the game is to work through each case to determine the correct diagnosis, and then choose the most appropriate treatment. While continuing through each case, players will learn about the differential diagnosis of AD, the role of S. aureus infection in AD, the tenets of good basic skin care for treating patients AD, appropriate use of topical corticosteroids, and the role of steroid-sparing agents and systemic treatments for patients with severe cases of AD.


Goal

The goal of this activity is to provide pediatric primary care practitioners with the tools and information they need to confidently and accurately diagnose and manage pediatric patients with AD.

Educational Objectives

Upon completion of this activity, participants will be better able to do the following:

  • DIFFERENTIATE AD from other dermatological conditions that may present in primary/pediatric care.
  • ASSESS AD severity based on symptom presentation to guide appropriate individualized management strategies.
  • IMPLEMENT the current and new treatments for AD in a primary care setting.

Disclosure of Conflicts of Interest

It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty Relationship Identified With:
Elaine C. Siegfried, MD Consultant/Advisor: Dermavant Sciences Inc, Eli Lilly and Company, GlaxoSmithKline plc, LEO Pharma Inc, Pierre Fabre S.A, and Regeneron Pharmaceuticals, Inc.
Speakers’ Bureau: Pfizer Inc.
Tonya McClain, RN, MSN, CPNP-PC Has no financial relationships to disclose

Non-faculty

Sandy Breslow; Alison Kemp; Bernard M. Abrams, MD; Gordon Ringler;Daniel Guinee; Mary Gabb, MS; and, Lisa Mangione hereby state that neither they nor their spouse/life partner have any financial relationships to products or devices with any commercials interest related to the content of this activity of any amount during the past 12 months.

Financial Support

This activity has been supported by independent educational grants from Sanofi Genzyme and Regeneron Pharmaceuticals and Pfizer Inc.

Provider Information

Jointly provided by the Elsevier Office of Continuing Medical Education, Dannemiller, and ASiM CE LLC.

   

CME CREDIT (PHYSICIANS)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Elsevier Office of Continuing Medical Education and ASiM CE LLC, The Elsevier Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

EACCME

The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at mutualrecognition@uems.eu. Additional information on the process of converting AMA PRA Category 1 Credit™ to ECMECs® can be found at: www.eaccme.eu.

CNE CREDIT (NURSES)




In support of improving patient care, this activity has been planned and implemented by Dannemiller and Elsevier Office of Continuing Medical Education. Dannemiller is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Dannemiller designates this educational activity for 0.5 contact hour.

CME INQUIRIES/SPECIAL NEEDS

For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, Dannemiller, ASiM CE LLC, Sanofi Genzyme and Regeneron Pharmaceuticals and Pfizer Inc do not recommend the use of any agent outside of the labeled indications.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of participation

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Nurses who attain a grade of 70% on the post-activity test question and who complete the evaluation before the expiration date will receive a certificate of completion for 1.0 contact hour. There is no partial credit that will be awarded for this activity.
  6. Physicians who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME Certificate.
  7. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.

Release date: October 31, 2018
Expiration date: October 31, 2019